Kuhr, T; Apfelbeck, U; Linkesch, W; Mistrik, M; Tothova, E; Koza, V; Lutz, D; Vorlieek, J; Cernelc, P; Bernhart, M; Lin, W; Hausmaninger, H; Greil, R; Gastl, G; Michlmayr, G; Thaler, J
Treatment of newly-diagnosed CML patients with interferon alpha and continuous versus intermittent cytarabin-ocfosfat (YNK01): A randomized Central European Leukemia Study.
BLOOD 2003 102: 311B-311B.
Web of Science
Kuehr, T; Burgstaller, S; Apfelbeck, U; Linkesch, W; Mistrik, M; Tothova, E; Koza, V; Greil, R; Michlmayr, G; Lutz, W; Thaler, J
Interferon alpha in combination with intermittent versus continuous YNK01 in patients with CML in early chronic phase: Preliminary results of a randomized phase III study.
BLOOD 2002 100: 328B-328B.
Web of Science
Neumeister, P; Hofler, G; BehamSchmid, C; Schmidt, H; Apfelbeck, U; Linkesch, W; Sill, H
Homozygous deletions of the p16 gene in high-grade gastric malt lymphomas.
BLOOD 1996 88: 3311-3311.
Web of Science